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Abstract
Background: For patients with chronic liver disease, different optimal liver stiffness cut-off values correspond to
different stages of fibrosis, which are specific for the underlying liver disease and population.
Aims: To establish the normal ranges of liver stiffness in the healthy Chinese population without underlying liver
disease.
Methods: This is a prospective cross sectional study of 2,528 healthy volunteers recruited from the general
population and the Red Cross Transfusion Center in Hong Kong. All participants underwent a comprehensive
questionnaire survey, measurement of weight, height, and blood pressure. Fasting liver function tests, glucose and
cholesterol was performed. Abdominal ultrasound and transient elastography were performed on all participants.
Results: Of the 2,528 subjects, 1,998 were excluded with either abnormal liver parenchyma on ultrasound, chronic
medical condition, abnormal blood tests including liver enzymes, fasting glucose, fasting cholesterol, high body mass
index, high blood pressure, or invalid liver stiffness scan. The reference range for the 530 subjects without known
liver disease was 2.3 to 5.9 kPa (mean 4.1, SD 0.89). The median liver stiffness was higher in males compared with
females (4.3 vs 4.0 kPa respectively, p<0.001). There was also a decline in median Lliver stiffness in the older age
group, from 4.2 kPa in those <25 years to 3.4 kPa for those >55 years (p=0.001).
Conclusions: The healthy reference range for liver stiffness in the Chinese population is 2.3 to 5.9 kPa. Female
gender and older age group was associated with a lower median liver stiffness.
Citation: Fung J, Lee C-k, Chan M, Seto W-k, Wong DK-h, et al. (2013) Defining Normal Liver Stiffness Range in a Normal Healthy Chinese Population
without Liver Disease. PLoS ONE 8(12): e85067. doi:10.1371/journal.pone.0085067
Editor: Seung Up Kim, Yonsei University College of Medicine, Korea, Republic Of
Received August 19, 2013; Accepted November 22, 2013; Published December 26, 2013
Copyright: © 2013 Fung et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Hong Kong Liver Health Census was an investigator-initiated, not-for-profit study, in conjunction with the Hong Kong Liver Foundation.
Financial support was provided by unrestricted grants from Bristol-Myers-Squibbs (Hong Kong), Chong Lap (Hong Kong), GlaxoSmithKline,(Hong Kong)
and Novartis Pharmaceuticals (Hong Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The Hong Kong Liver Health Census was an investigator-initiated, not-for-profit study, in conjunction with the Hong Kong Liver
Foundation. Financial support for provided by unrestricted grants from Bristol-Myers-Squibbs (Hong Kong), Chong Lap (Hong Kong), GlaxoSmithKline,
(Hong Kong) and Novartis Pharmaceuticals (Hong Kong). Each author has declared no conflict of interest with the sponsors for this study. This does not
alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: mfyuen@hkucc.hku.hk
Introduction
For people with chronic liver diseases, assessment of liver
fibrosis is important for several reasons. Firstly, the degree of
fibrosis is an indication of the severity of the underlying liver
disease. Secondly, it may have prognostic significance. In
addition, treatment decisions may be dependent on the
presence of significant fibrosis. Although liver biopsy remains
the gold standard for assessing liver fibrosis, patients may be
unwillingly to undergo a biopsy procedure and clinicians may
be reluctant to advocate it because of the potential adverse
effects associated with this invasive procedure [1,2].
Furthermore, there are also disadvantages associated with
liver biopsy. Its accuracy is dependent on the quality of tissue
sample obtained, including the number of portal tracts, length
of specimen, and degree of fragmentation. As biopsies only
sample tiny portions of the liver, they are subjected to sampling
errors. Its interpretation is further subjected to intra- and inter-
observer variability [3]. For these reasons, non-invasive
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methods to assess liver fibrosis have been developed as an
alternative to liver biopsy.
In the past decade, liver stiffness measurement (LSM) using
transient elastography has become one of the most viable
alternative non-invasive methods to biopsy in assessing liver
fibrosis. Previous studies have documented the diagnostic
accuracy of LSM in grading fibrosis for a variety of chronic liver
diseases [4-8]. In addition, LSM has been shown to have
prognostic significance in predicting long-term outcome, and in
the assessment of treatment response [9,10]. One of the
earliest key concepts of LSM to evolve is that different optimal
liver stiffness cut-off values correspond to different stages of
fibrosis, and these cut-off values are disease-specific [4-7].
Although cut-off values for advanced fibrosis and cirrhosis have
been well established for different diseases, the normal
reference range of LSM in specific population groups have not
been well defined, especially from large population studies.
Histology from normal liver is rarely available, therefore normal
ranges of liver stiffness is much harder to establish. An earlier
small-scaled study using normal livers from subjects
undergoing donor hepatectomy have identified a normal cut-off
liver stiffness of <7.2 kPa [11].
The Hong Kong Liver Health Census was established in
2010 by a group of hepatologists from the University of Hong
Kong in collaboration with the Hong Kong Liver Foundation and
Hong Kong Red Cross Blood Transfusion Service. The aim of
the current study was to define the normal ranges of liver
stiffness in the healthy Chinese population without underlying
liver disease.
Subjects and Methods
The Liver Health Census recruited participants from blood
donors of the Hong Kong Red Cross Blood Transfusion
Services and volunteers from the general population. All
participants included in the census were screened negative for
hepatitis B surface antigen (HBsAg), antibody to hepatitis C
virus (anti-HCV), and human immunodeficiency virus (HIV).
Ultrasound of the abdomen and transient elastography was
performed in all participants. Laboratory blood testing was
performed on the same day. All participants underwent weight,
height, and completed a detailed questionnaire.
Ethics statement
Written informed consent was obtained from all participants.
The study was approved by the Institutional Review Board of
the University of Hong Kong and Hospital Authority Western
Cluster (No. UW-10-325).
Liver stiffness measurement
LSM was performed using transient elastography (Fibroscan,
Echosens, Paris) by an experienced operator. The procedure
has been described previously [12]. Briefly, LSM was
performed with the subject lying in the supine position. Using
time-motion ultrasound image, measurements were obtained
once a segment of the liver was located with a thickness of
over 6cm and free of large vascular structures. Results were
included in the final analysis only if the following three criteria
were met: at least 10 valid measurements, success rate >60%
and the interquartile range (IQR)-to-liver stiffness ration were
≤0.30. The median liver stiffness value of each participant was
representative of the liver stiffness, and expressed in units of
kilopascals (kPa).
Abdominal ultrasound
All participants underwent abdominal ultrasonography by two
experienced radiologists, using the Envisor ultrasound system
(Philips Ultrasound, Philips Medical System, The Netherlands).
Fatty liver was diagnosed by the presence of increased liver
echogenicity.
Detailed questionnaire
All participants completed a detailed questionnaire including
their past and current medical history, and their current intake
of medications, herbal remedies, over-the-counter remedies,
and alcohol.
Laboratory test
Participants were excluded from the census if prior testing
indicated they were infected with hepatitis B, hepatitis C, or
HIV. Fasting blood tests were performed on the same day of
the ultrasound and transient elastography. Liver biochemistry
including alanine aminotransferase (ALT), gamma-glutamyl
transferase (GGT) and bilirubin levels were measured, along
with cholesterol and glucose.
Statistical analysis
All statistical analysis was performed using SPSS version
16.0 (Chicago, IL). Continuous variables with skewed
distribution were analyzed using the Mann-Whitney test.
Continuous variables with more than two categories were
analyzed using the Kruskal Wallis test. The correlation co-
efficient between LSM and other parameters were calculated
using the Pearson test. The reference range was calculated
using the mean ±2 standard deviations. A p-value of <0.05 was
considered statistically significant.
Results
A total of 2,528 subjects were enrolled into the liver health
census. As mentioned previously, these subjects were already
screened negative for HBV, HCV, and HIV infection. To define
a normal liver stiffness range in healthy individuals without
known liver disease, we excluded also those with
sonographical evidence of fatty liver disease (n=1070) and
fibrosis/cirrhosis (n=4). Next, those with pre-existing diabetes,
hypertension, other chronic medical conditions, and significant
alcohol intake (as defined by >20g/day) were excluded
(n=120). Those with elevated bilirubin (>17.1 umol/L), ALT (>45
U/L), GGT >84 U/L), fasting glucose (>6.0 mmol/L)[13], fasting
cholesterol (>5.0 mmol/L)[14], and low albumin (<35 g/L) were
then excluded (n=591). A further 207 patients were excluded
with higher BMI (>23 kg/m2) or elevated blood pressure
(systolic >140 mmHg or diastolic >90 mmHg)[15]. In the
remaining 536, 6 (1%) subjects had invalid transient
Normal Liver Stiffness in Chinese Subjects
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elastography measurements (as defined by the criteria set
above), and were excluded. This is consistent with the
predicted failure rate of <5%[16].
The remaining 530 participants had valid LSM and were
included in the final analysis. The flow of participants is outlined
in Figure 1. Basic demographics and characteristics are
summarized in Table 1. All patients in the final analysis
therefore had normal liver parenchyma on ultrasonography,
normal liver enzymes, absence of chronic medical condition, no
significant alcohol intake, and normal fasting glucose and
cholesterol and normal BMI. The laboratory and liver stiffness
results are summarized in Table 2.
Correlation of LSM with patient parameters
There was a negative correlation between age and LSM
(r=-0.168, p<0.001). The LSM for those with age ≤25, 26-35,
Figure 1.  Flow diagram of health participants from the Hong Kong Liver Health Census.  
doi: 10.1371/journal.pone.0085067.g001
Table 1. Basic demographics and characteristics of healthy participants.
Parameters Values
Number of participants (N) 530
Age (years) 37 (18-63)
Male sex [n(%)] 141 (26.6%)
Body mass index (kg/m2) 20.6 (16.0 - 23.0)
Systolic blood pressure (mmHg) 108 (80 - 139)
Diastolic blood pressure (mmHg) 66 (49 - 89)
Continuous variables expressed as median (range)
doi: 10.1371/journal.pone.0085067.t001
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36-45, 46-55, and >55 years were 4.2, 4.3, 4.0, 3.8, and 3.4
kPa respectively (p=0.001), as shown in Figure 2. The median
LSM in males was higher than females (4.3 vs 4.0 kPa
respectively, p<0.001)(Figure 3). There was no correlation
observed between LSM and BMI (r=-0.72, p=0.097), systolic
blood pressure (r=0.061, p=0.162), and diastolic blood
pressure (r=0.014, p=0.743).
Correlation of LSM with laboratory parameters
There was no significant correlation between LSM and
fasting cholesterol (r=-0.61, p=0.163), fasting glucose (-0.78,
p=0.071), ALT (r=0.072, p=0.100), and GGT (r=0.072,
p=0.100). There was a weak correlation between LSM and
bilirubin (r=0.096. p=0.028).
Normal reference range
The reference range for liver stiffness was determined for the
current healthy population without known liver disease. The
mean was determined, and the range of normal values was
established by calculating ±2 standard deviations from the
mean. The reference range for the 530 subjects without known
liver disease was 2.3 to 5.9 kPa (mean 4.11, SD 0.89), with the
Table 2. Laboratory results and liver stiffness results of participants.
Parameters Values
Blood tests  
Bilirubin (umol/L) 8.9 (2.1-16.9)
Alanine aminotransferase (U/L) 30 (16 - 45)
Gamma glutaryltransferase (U/L) 23 (9 - 73)
Albumin (g/L) 41 (36-50)
Fasting glucose (mmol/L) 4.8 (3.9 - 6.0)
Fasting cholesterol (mmol/L) 4.8 (2.6 - 5.0)
Liver stiffness measurement  
Liver stiffness (kPa) 4.1 (1.9 - 7.8)
Interquartile range 0.5 (0.0 - 1.6)
Success rate 100% (71 - 100)
Interquartile range to liver stiffness ratio 0.13 (0.00 - 0.30)
Continuous variables expressed as median (range).
doi: 10.1371/journal.pone.0085067.t002
Figure 2.  Liver stiffness according to gender.  
doi: 10.1371/journal.pone.0085067.g002
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distribution shown in Figure 4. The reference range was similar
between males and females (2.6 to 6.1 kPa and 2.3 to 5.8 kPa
respectively).
Discussion
In recent years, transient elastography has become more
widely available for the non-invasive assessment of liver
Figure 3.  Liver stiffness according to different age groups.  
doi: 10.1371/journal.pone.0085067.g003
Figure 4.  The distribution and normal range of liver stiffness in normal subjects.  
doi: 10.1371/journal.pone.0085067.g004
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fibrosis. There are well-established optimal cut-off values for
different stages of fibrosis, which appear to be specific for
individual diseases and populations. Normal ranges for liver
stiffness have been less well defined due to the lack of large
population studies on healthy subjects. Histological specimens
from normal livers in subjects without liver disease are
expectedly rare. However, a large population study of normal
healthy subjects is essential to derive a normal reference range
of liver stiffness, which provides a solid and firm reference for
populations with liver disease
The current study included participants from The Hong Kong
Liver Health Census, selecting those without ultrasonographic
evidence of fatty liver, fibrosis, and cirrhosis. In addition, none
of these subjects were hepatitis B carriers, a disease that
continues to be endemic with a prevalence rate of 8% in our
general population. The study identified a healthy liver stiffness
range of 2.3 to 5.9 kPa in the Chinese population.
A recent study on 437 South Asian subjects showed a
reference range to be 3.2 and 8.5 kPa by calculating the 5th
and 95th percentile respectively [17]. A higher LSM was
identified in lean and obese subjects. As the current study
excluded subjects with high BMI (>23 kg/m2), no correlation
between liver stiffness and BMI was observed among those
with normal BMI, Another study of 445 South Asian subjects
without known liver disease and normal liver enzymes showed
a mean LSM of 5.1 kPa, with both ALT and BMI influencing the
LSM significantly [18]. These differences highlight the important
fact that liver stiffness values are not universal, and reference
ranges should be derived for different populations.
Although there was correlation shown between LSM and
bilirubin, the correlation was very weak only. A previous large
population study of 1,268 chronic hepatitis B Chinese patients
demonstrated that LSM correlated with higher age and also
increasing levels of ALT [12]. It has long been realized that ALT
was a significant independent factor in which markedly
elevated ALT levels can increase the LSM spuriously [19,20].
Another study also showed that even small increments in ALT
were associated with higher LSM in CHB patients [21]. There
was no correlation between liver stiffness and ALT in the
current study. This is likely due to the fact that only those with
normal ALT were included.
In a previous study of 428 patients with normal liver enzymes
and no known liver disease, the liver stiffness was significantly
higher in males compared with females [22]. This is also
consistent with our current study showing a higher median
stiffness in males compared with females (4.3 vs 4.0 kPa
respectively, p<0.001). However, this difference is minimal, and
therefore having separate normal ranges is unlikely to be
useful.
One limitation of the current study is the unavailability of liver
biopsies to confirm the absence of fibrosis in the study
population. However, the use of liver biopsies in a large
population of healthy individuals is unlikely to be feasible. By
using stringent criteria to define a healthy population, the
margin of error is likely to be minimized. Despite this,
undiagnosed liver diseases may still occur. Although viral
serology for HBV, HCV, and HIV were performed, neither
hepatitis B core antibody (anti-HBc) nor autoimmune antibodies
were screened to exclude past HBV infection and autoimmune
liver diseases respectively.
In conclusion, the normal range for liver stiffness in the
Chinese population is 2.3 to 5.9 kPa. Female gender and older
age were associated with lower liver stiffness in subjects
without known liver disease.
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